Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma

NCT00538824 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped low enrollment

Conditions

Multiple Myeloma

Interventions

DRUG: dexamethasone
DRUG: thalidomide
DRUG: lenalidomide

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]